| Literature DB >> 26344588 |
Demetrio Raffa1, Benedetta Maggio2, Fabiana Plescia3, Stella Cascioferro3, Maria Valeria Raimondi3, Gabriella Cancemi3, Antonella D'Anneo4, Marianna Lauricella5, Maria Grazia Cusimano3, Ruoli Bai6, Ernest Hamel6, Giuseppe Daidone3.
Abstract
Several new 2-(2-phenoxyacetamido)benzamides 17a-v, 21 and 22 were synthesized by stirring in pyridine the acid chlorides 16a-e and the appropriate5-R-4-R₁-2-aminobenzamide 15a-e and initially evaluated in vitro for antiproliferative activity against the K562 (human chronic myelogenous leukemia) cell line. Some of synthesized compounds were evaluated for their in vitro antiproliferative activity against the full NCI tumor cell line panel derived from nine clinically isolated cancer types (leukemia, non-small cell lung, colon, CNS, melanoma, ovarian, renal, prostate and breast). The most active compounds caused an arrest of K562 cells in the G0-G1 phase of cell cycle and induction of apoptosis, which was mediated by caspase activation.Entities:
Keywords: 2-(2-Phenoxyacetamido)benzamides; Antiproliferative activity; Apoptosis; G0/G1 arrest; Pro-caspase 3
Mesh:
Substances:
Year: 2015 PMID: 26344588 PMCID: PMC4593655 DOI: 10.1016/j.bmc.2015.08.027
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641